Get the Stockscreener App
0.2218
3.57%
-0.0082
Sunshine Biopharma Inc stock is traded at $0.2218, with a volume of 877.03K.
It is down -3.57% in the last 24 hours and down -78.47% over the past month.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
See More
Previous Close:
$0.23
Open:
$0.221
24h Volume:
877.03K
Relative Volume:
0.03
Market Cap:
$859.99K
Revenue:
$35.49M
Net Income/Loss:
$-6.04M
P/E Ratio:
-0.017
EPS:
-13.0191
Net Cash Flow:
$-6.42M
1W Performance:
-34.34%
1M Performance:
-78.47%
6M Performance:
-97.80%
1Y Performance:
-98.99%
1-Day Range:
$0.205
$0.2292
1-Week Range:
$0.1855
$0.3295
52-Week Range:
$0.1855
$24.30
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Name
Sunshine Biopharma Inc
Sector
Phone
954-330-0684
Address
333 LAS OLAS WAY, FORT LAUDERDALE
Compare SBFM vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
0.2218 | 859.99K | 35.49M | -6.04M | -6.42M | -13.02 |
TAK
Takeda Pharmaceutical Co Adr
|
19.67 | 62.84B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.50 | 48.40B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.13 | 44.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.38 | 32.80B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
533.12 | 22.87B | 3.17B | 1.29B | 1.01B | 27.09 |
Sunshine Biopharma Inc Stock (SBFM) Latest News
Sunshine Biopharma Closes $6 Million Equity Offering - marketscreener.com
Sunshine Biopharma Completes $6 Million Public Offering - The Globe and Mail
Form 4 Sunshine Biopharma Inc For: 9 October By Investing.com - Investing.com Nigeria
Sunshine Biopharma Taps Aegis for $6 Million Public Offering of Units and Warrants - TradingView
Sunshine Biopharma, Inc. (SBFM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Sunshine Biopharma Announces Closing of up to $20.4 Million Public Offering - ACCESS Newswire
Sunshine Biopharma Inc. (SBFM) Closes ~$6.0M Offering; Up to $14.4M via Warrants - TradingView
Sunshine Biopharma Inc. (SBFM) Closes $6.0M Offering; Up To $14.4M More If Warrants Exercise - TradingView
Sunshine Biopharma Prices $6 Million Public Offering at $0.55 Per Unit, Raising Dilution Concerns - Yahoo Finance
Sunshine Biopharma (SBFM) Announces $6M Public Offering at $0.55 per Unit - GuruFocus
Sunshine Biopharma (SBFM) Prices $6M Public Offering with Warran - GuruFocus
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering - Weatherford Democrat
Sunshine Biopharma Inc. (SBFM) Prices ~$6.0M Offering - TradingView
SBFM Stock Pops As Sunshine Biopharma Pushes Antiviral, Generics - Timothy Sykes
SBFM Stock Attracts Traders As Antiviral And Generics Story Builds - StocksToTrade
Sunshine Biopharma Inc. SEC Filing (Oct 8, 2026) - Stock Titan
Sunshine Biopharma Soars as Traders Appear to Chase a Speculative Rebound - Moomoo
Sunshine Biopharma Soars as Traders Appear to Chase a Speculative Rebound - Quiver Quantitative
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Warrants for 200,000 shares feature in Alta’s amended Sunshine Biopharma (SBFM) stake report. - Stock Titan
Shares traded below Nasdaq’s $1 minimum. Sunshine Biopharma (SBFM) has approved a possible reverse split. - Stock Titan
Sunshine Biopharma, Inc. (SBFM) Upgraded to Buy: Here's What You Should Know - finance.yahoo.com
Sunshine Biopharma launches generic ondansetron in Canada - Investing.com
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio - Corsicana Daily Sun
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio - Times Argus
A generic drug for nausea during cancer treatment launches in Canada - Stock Titan
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio - FinancialContent
Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio - Yahoo Finance
Sunshine Biopharma Stock (SUNB) Opinions on Coronavirus Drug Studies - Quiver Quantitative
Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies - Yahoo Finance
An oral drug candidate suppressed lung virus in infected mice - Stock Titan
EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies - Yahoo Finance
Sunshine Biopharma Inc. (NASDAQ:SBFM) Advances Lead COVID Antiviral to IND-Enabling Studies - TradingView
Form 8K Sunshine Biopharma Inc For: 11 September By Investing.com - Investing.com South Africa
Sunshine Biopharma reduces Series B warrant exercise price to $1.2046 By Investing.com - Investing.com South Africa
Sunshine Biopharma reduces Series B warrant exercise price to $1.2046 - Investing.com
Sunshine Biopharma reduces Series B warrant exercise price to $1.2046 By Investing.com - Investing.com India
Form 8K Sunshine Biopharma Inc For: 11 September By Investing.com - Investing.com Canada
Form 8K Sunshine Biopharma Inc For: 11 September By Investing.com - Investing.com UK
Sunshine Biopharma cuts warrant exercise price to 1.2 - Bitget
Sunshine Biopharma (NASDAQ: SBFM) Anticipates $31M from Series B Warrant Exercises - kalkinemedia.com
Price to earnings forward of Sunshine Biopharma Inc. – BOATS:SBFMW - TradingView
Price to sales forward of Sunshine Biopharma Inc. – BOATS:SBFMW - TradingView
Sunshine Biopharma Inc. SEC Filing (Sep 9, 2026) - Stock Titan
Sunshine Biopharma receives Canadian approval for atenolol tablets By Investing.com - Investing.com Nigeria
Sunshine Biopharma Announces Board Vacancy as Dr. Andrew Keller Steps Down After Term Ends - kalkinemedia.com
SBFM Looks 52.9% Undervalued on GF Value™ Despite Weak Fundamentals - GuruFocus
Sunshine Biopharma receives Canadian approval for atenolol tablets By Investing.com - Investing.com India
Sunshine Biopharma receives Canadian approval for atenolol tablets By Investing.com - Investing.com UK
Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions - Cadillac News
Sunshine Biopharma Inc Stock (SBFM) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.51%
5.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):